Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0904-7213

3 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0904-7213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of Acamprosate Calcium showing its molecular arrangement including the calcium ion (Ca2+).*
FDA Label Image
FDA Label Image

333mg Carton Label (6560e0ea E882 4fcd B523 8c5474d32f91 00)

333mg Carton Label (6560e0ea E882 4fcd B523 8c5474d32f91 00)
Acamprosate Calcium Delayed-Release Tablets 333 mg unit dose packaging label by Major Pharmaceuticals. The label includes the NDC 0904-7213-04, quantity of 30 tablets (3 x 10), and specifies Rx only. It provides storage instructions, dosing directions reference, and a statement that the unit dose is not child resistant and intended for institutional use only. Distributed by Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.